EcoDrugPlus

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000022347
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000024554
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000023325
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000021874
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000028865
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000023112
Gene Symbol: MC4R
1 Cross references
74 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSXMAG00000029636
Gene Symbol: MC4R
2 Cross references
75 Possible Orthologues:

Melanocortin Receptor 4

Ensembl ID : ENSXMAG00000025523
Gene Symbol: LOC102235203
4 Cross references
74 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSXMAG00000027195
Gene Symbol: LOC111606145
4 Cross references
74 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSXMAG00000021839
Gene Symbol: LOC102234594
3 Cross references
74 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSXMAG00000029547
Gene Symbol: LOC111605751
3 Cross references
74 Possible Orthologues:

Melanoma Receptor Tyrosine-Protein Kinase

Ensembl ID : ENSXMAG00000024944
Gene Symbol: LOC102228937
2 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).